新诺威：拟共同投资设立合资公司 聚焦于GLP-1靶点等相关产品

Group 1 - The core point of the article is that XinNuoWei (300765) announced plans to establish a joint venture with Zhongqi Pharmaceutical, contributing a total of 450 million yuan, with XinNuoWei investing 158 million yuan for a 35% stake in the new company [1] - The joint venture will focus on the research, industrialization, and commercialization of innovative metabolic drugs, particularly targeting GLP-1 related products [1] - The new company will take over the entire pipeline of GLP-1 related products from Shiyao Group Co., Ltd., which includes treatments for overweight/obesity and type 2 diabetes, and will continue to develop new formulations and expand indications [1]